D

Precision BioSciences

D
DTIL
USD
-0.12
(-1.4151%)
Market Closed
1,015.00
Volume
5.15
EPS
-
Div Yield
31.824
P/E
60,474,233.60
Market Cap
Today
-1.4151%
1 Week
-2.336%
1 Month
-9.524%
6 Months
-20.758%
12 Months
-30.697%
Year To Date
-24.501%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
E
EDIT
-0.11
(-3.3537%)
USD
C
CRSP
1.04
(2.0444%)
USD
S
SGMO
0.33
(13.3603%)
USD
N
NTLA
0.31
(1.9745%)
USD
B
BEAM
-0.53
(-1.991%)
USD
V
VYGR
0.455
(6.8576%)
USD
REGN
REGN
-3.78
(-0.4561%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
T
TECH
0.65
(0.8572%)
USD

Title:
Precision BioSciences

Sector:
Healthcare
Industry:
Biotechnology
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Do you need help or have a question?
Contact Us